TCM
BDSI

Traynor Capital Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Traynor Capital Management’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-20,000
Closed -$69K – 178
2017
Q2 		$69K Buy
+20,000
New +$42.2K 0.03% 155

Other funds holding BDSI

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Traynor Capital Management's BDSI Position: Q3 2017 in Review

Traynor Capital Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q3 2017, closing a stake of 20,000 shares — an estimated $69K sold.

Traynor Capital Management first reported a position in BDSI in Q2 2017 and held it in 1 quarter. The position peaked at $69K in Q2 2017. 62 funds tracked by Wall St. Rank hold BDSI as of Q3 2017.

  • Traynor Capital Management reported no remaining BioDelivery Sciences International, Inc. position as of Q3 2017 after selling out during the quarter.
  • Traynor Capital Management sold 20,000 BioDelivery Sciences International, Inc. shares in Q3 2017, an estimated $69K.
  • Traynor Capital Management first reported a position in BioDelivery Sciences International, Inc. in Q2 2017 and held it in 1 quarter.
  • Traynor Capital Management's BioDelivery Sciences International, Inc. position peaked at $69K in Q2 2017.
  • 62 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q3 2017.

Based on Traynor Capital Management's 13F filing for Q3 2017, filed 27 Oct 2017.